Zomedica Corp. (ZOMDF) KPIs and segments
Close on Oct 19, 2026Market cap $77.40MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Zomedica's business
Zomedica's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Therapeutic Devices($M)3 | 6.75 | 5.82 | 7.40 | 6.67 | 6.18 | 5.94 | 7.13 | 6.49 | 5.71 | 5.52 | 6.98 | 5.98 | |
Consumables($M) | 5.11 | 4.37 | 4.38 | 4.63 | 4.74 | 4.09 | 4.21 | 4.37 | 4.07 | 3.72 | 3.84 | 4.29 | |
Capital($M) | 1.63 | 1.43 | 3.00 | 2.01 | 1.43 | 1.80 | 2.90 | 2.07 | 1.61 | 1.77 | 3.12 | 1.67 | |
Other($M) | 0.02 | 0.02 | 0.02 | 0.04 | 0.02 | 0.05 | 0.02 | 0.05 | 0.04 | 0.03 | 0.02 | 0.02 | |
Diagnostics($M)2 | 1.39 | 0.97 | 0.70 | 0.76 | 0.78 | 0.56 | 0.76 | 0.51 | 0.42 | 0.74 | 0.36 | 0.37 | |
Consumables($M) | 1.18 | 0.80 | 0.58 | 0.57 | 0.55 | 0.40 | 0.37 | 0.34 | 0.29 | 0.29 | 0.21 | 0.19 | |
Capital($M) | 0.21 | 0.17 | 0.12 | 0.19 | 0.23 | 0.16 | 0.39 | 0.17 | 0.13 | 0.45 | 0.15 | 0.18 | |
Development Services($M)4 | 1.37 | 2.01 | 2.37 | 0.66 | |||||||||
Engineering($M) | 0.98 | 1.24 | 1.49 | 0.48 | |||||||||
Consumables($M) | 0.36 | 0.30 | 0.54 | 0.18 | |||||||||
Other($M) | 0.03 | 0.09 | |||||||||||
Capital($M) | 0.00 | 0.37 | |||||||||||
Consumables($M) | 6.65 | 5.47 | 5.51 | 5.38 | 5.29 | 4.50 | 4.58 | 4.71 | 4.36 | 4.01 | 4.05 | 4.48 | |
Capital($M) | 1.84 | 1.97 | 3.45 | 2.20 | 1.65 | 1.96 | 3.30 | 2.24 | 1.73 | 2.22 | 3.27 | 1.85 | |
Engineering($M) | 0.98 | 1.24 | 1.49 | 0.48 | |||||||||
Other($M) | 0.05 | 0.11 | 0.02 | 0.04 | 0.02 | 0.05 | 0.02 | 0.05 | 0.04 | 0.03 | 0.02 | 0.02 | |
United States($M) | 7.86 | 7.38 | 9.12 | 6.73 | 5.56 | 5.05 | 6.68 | 5.82 | 4.90 | 5.16 | |||
Foreign countries($M) | 1.65 | 1.42 | 1.35 | 1.37 | 1.40 | 1.45 | 1.22 | 1.18 | 1.23 | 1.10 | |||
Therapeutic Devices($M) | 4.52 | 4.05 | 5.57 | 4.88 | 4.47 | 4.41 | 5.55 | 4.95 | 4.41 | 3.96 | 5.53 | 4.47 | |
Development Services($M) | 0.77 | 1.09 | 1.65 | 0.41 | |||||||||
Diagnostics($M) | 0.76 | 0.35 | -0.05 | 0.15 | 0.19 | 0.00 | -0.00 | 0.11 | -0.04 | 0.16 | -0.46 | -0.11 | |
15 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-05.
See a number that looks wrong?